CHAPEL HILL, N.C., Jan. 24 /PRNewswire-FirstCall/ -- POZEN Inc.
(Nasdaq: POZN), a pharmaceutical development company with a portfolio of
product candidates for the treatment of migraine, announced that John R.
Plachetka, Pharm. D., the company's chairman, president and chief executive
officer, will make a presentation to investors and financial analysts during
the U.S. Bancorp Piper Jaffray Health Care Conference. The presentation is
scheduled for Tuesday, January 29, 2002 at 11:30 a.m. EST at the Pierre Hotel
in New York. The presentation will also be broadcast live through the
Internet and will remain archived for 30 days. The webcast information is as
Webcast Location for Real Player:
Webcast Location for Windows Media Player:
North Carolina-based POZEN Inc. is a pharmaceutical development company
committed to building a portfolio of products with significant commercial
potential in select therapeutic areas. POZEN's initial focus is on developing
products for migraine therapy, a global market expected to exceed $2.6 billion
this year. The company's common stock is traded on The Nasdaq Stock Market
under the symbol "POZN."
POZEN is on the Internet at www.pozen.com
Chief Financial Officer, of POZEN
Kathy Brunson of FRB Weber Shandwick